Clinical Trial Update: Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis [Phase 3]

View source ↗

Summary

Phase 3 trial data evaluate the efficacy and safety of 17-Beta Estradiol for treating postmenopausal vaginal atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Vaginal Atrophy

Drugs mentioned

• 17-Beta Estradiol (17-beta estradiol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Postmenopausal Vaginal Atrophy | Phase 3 | Status: COMPLETED